Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in the People's Republic of China. It offers drugs in the oncology, metabolic diseases, digestive system, and other therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology promotion, and medical aesthetic research and development services. The company was founded in 2001 and is based in Wanchai, Hong Kong.

Sihuan Pharmaceutical Holdings Group Ltd.

四环医药 is focused on medical aesthetics and innovative biopharmaceuticals, offering a diversified product portfolio covering areas such as medical aesthetics, oncology, metabolism, diabetes, cardiovascular diseases, and modern traditional Chinese medicine/industrial hemp.

四环医药

Sihuan Pharmaceutical Holdings Group | 389 followers on LinkedIn. 四环医药控股集团有限公司成立于2001年，经过十余年的发展，现已成为中国医院处方药市场位列第四的领先制药企业，就市场份额而言，已成为全国最大的心脑血管处方药物供货商。四环医药的成功源于其拥有独特的销售模式、领先市场的产品组合、覆盖全国的网络及雄厚的研发能力。

0460

COM:SIHUANPHARM

四环医药

Last Close

0.70

22/11 08:08

Market Cap

5.20B

Beta: -

Volume Today

17.55M

Avg: -